Literature DB >> 8617147

Pleuropericarditis related to the use of mesalamine.

N Gujral1, F Friedenberg, J Friedenberg, G Gabriel, M Kotler, G Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8617147     DOI： 10.1007/bf02282352

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease.

Authors:  H Jenss; E W Becker; P Weber
Journal:  Am J Gastroenterol       Date:  1990-03       Impact factor: 10.864

2.  Fatal myocarditis associated with mesalazine.

Authors:  K S Kristensen; A Høegholm; L Bohr; S Friis
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

3.  Cardiac hypersensitivity to 5-aminosalicylic acid.

Authors:  J Agnholt; H T Sørensen; S N Rasmussen; C O Gøtzsche; P Halkier
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

4.  Sulphasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis.

Authors:  G Deboever; R Devogelaere; G Holvoet
Journal:  Am J Gastroenterol       Date:  1989-01       Impact factor: 10.864

5.  Absorption, metabolism, and excretion of salicylazosulfapyridine in man.

Authors:  H Schröder; D E Campbell
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

6.  Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study.

Authors:  H Sandberg-Gertzén; G Järnerot; C Tysk
Journal:  Scand J Gastroenterol Suppl       Date:  1988

Review 7.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

8.  Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.

Authors:  D L Carr-Locke
Journal:  Am J Gastroenterol       Date:  1982-09       Impact factor: 10.864

9.  Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

Authors:  P Miner; S Hanauer; M Robinson; J Schwartz; S Arora
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

10.  Sulfasalazine-induced lupus erythematosus.

Authors:  G L Clementz; B J Dolin
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965
View more
  12 in total

1.  Inflammatory Bowel Disease After Age 60.

Authors:  David A. Greenwald; Lawrence J. Brandt
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

2.  Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Authors:  Adam Harris; Shanti Eswaran; Brian Bosworth; Maya Gambarin-Gelwan; Ellen J Scherl
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-11

Review 3.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Folashade A Jose; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

4.  A large chronic pericardial effusion in an ultramarathon runner with anti-CCP positive rheumatoid arthritis.

Authors:  Thomas J McClelland; Rose Penfold; Stefan Kluzek; Navraj S Nagra
Journal:  BMJ Case Rep       Date:  2017-06-13

5.  Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients.

Authors:  Altug Cincin; Murat Sunbul; Tarık Kivrak; Halil Atas; Ibrahim Sari; Kursat Tigen; Tarik Kani; Hakan Akin; Nese Imeryuz; Yelda Basaran
Journal:  Dig Dis Sci       Date:  2014-07-15       Impact factor: 3.199

Review 6.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

7.  Chronic pericarditis and pericardial tamponade associated with ulcerative colitis.

Authors:  Mitchell S Cappell; Albert Turkieh
Journal:  Dig Dis Sci       Date:  2008-01       Impact factor: 3.199

8.  Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.

Authors:  Serge Perrot; Elisabeth Aslangul; Tali Szwebel; Houdha Gadhoum; Sophie Romnicianu; Claire Le Jeunne
Journal:  Int J Colorectal Dis       Date:  2007-04-18       Impact factor: 2.571

Review 9.  Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management of Pericarditis.

Authors:  Ravi S Patel; Sai Rohit Reddy; Adiona Llukmani; Ayat Hashim; Dana R Haddad; Dutt S Patel; Farrukh Ahmad; Domonick K Gordon
Journal:  Cureus       Date:  2021-03-20

10.  A case of acute myocarditis as the initial presentation of Crohn's disease.

Authors:  In Soo Oh; Chang Hwan Choi; Ji Hoon Park; Ju Wan Kim; Bong Ki Cha; Jae Hyuk Do; Sae Kyung Chang; Gui Young Kwon
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.